Neuralstem (CUR) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts CUR Hot Sheet
Price: $1.52 --0%
Financial Fact:
Total nonoperating income (expense): -303.28K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total nonoperating income (expense): -303.28K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Neuralstem (NYSE: CUR) reported Q1 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $2.92 million versus the consensus estimate of $160 thousand.
For earnings history and earnings-related data on Neuralstem (CUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
- Studio City International Holdings Limited (MSC) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
